↓ Skip to main content

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma

Overview of attention for article published in Cancer Discovery, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 3,391)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
120 news outlets
blogs
2 blogs
twitter
34 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma
Published in
Cancer Discovery, September 2021
DOI 10.1158/2159-8290.cd-20-1201
Pubmed ID
Authors

Diana M. Carvalho, Peter J. Richardson, Nagore Olaciregui, Reda Stankunaite, Cinzia Lavarino, Valeria Molinari, Elizabeth A. Corley, Daniel P. Smith, Ruth Ruddle, Adam Donovan, Akos Pal, Florence I. Raynaud, Sara Temelso, Alan Mackay, John P. Overington, Anne Phelan, David Sheppard, Andrew Mackinnon, Bassel Zebian, Safa Al-Sarraj, Ashirwad Merve, Jeremy Pryce, Jacques Grill, Michael Hubank, Ofelia Cruz, Andres Morales La Madrid, Sabine Mueller, Angel M. Carcaboso, Fernando Carceller, Chris Jones

Twitter Demographics

The data shown below were collected from the profiles of 34 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 21%
Student > Ph. D. Student 4 17%
Unspecified 2 8%
Student > Doctoral Student 1 4%
Professor > Associate Professor 1 4%
Other 2 8%
Unknown 9 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 25%
Unspecified 2 8%
Chemistry 2 8%
Immunology and Microbiology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 2 8%
Unknown 10 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 977. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2022.
All research outputs
#11,637
of 21,240,621 outputs
Outputs from Cancer Discovery
#2
of 3,391 outputs
Outputs of similar age
#508
of 347,353 outputs
Outputs of similar age from Cancer Discovery
#1
of 99 outputs
Altmetric has tracked 21,240,621 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,391 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,353 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.